Binding affinity for Bcl-2 and Bcl-xL
Biochemical assay · Bcl-2 and Bcl-xL binding assays [1]
The original supporting table reports Ki <1 nM for both targets for compound 2 (ABT-263).
| Endpoint | Reported result | Reference |
|---|---|---|
| Bcl-2 binding affinity | Ki < 1 nM | [1] |
| Bcl-xL binding affinity | Ki < 1 nM | [1] |
Literature-Reported Treatment Conditions
- Reported limits
- Main binding assay protocol, tested concentration range, incubation time, vehicle, replicate count and uncertainty were not available in the retrieved SI. Ki values are measurements, not treatment recommendations.
Methods and source locations
Compound reported in the paper: ABT-263 (Navitoclax); Compound label in the paper: 2 (ABT-263)
Compound-level research evidence; no batch, polymorph or Adooq validation claim.
Supporting information Table S1, pp. S2-S3, compound 2 row; Table S2 p. S4; main abstract compound-number mapping
Bcl-2 binding affinity — Supporting information Table S1, pp. S2-S3, compound 2 row; Table S2 p. S4; main abstract compound-number mapping
Bcl-xL binding affinity — Supporting information Table S1, pp. S2-S3, compound 2 row; Table S2 p. S4; main abstract compound-number mapping